Takeyoshi Eda

Dramatic response of BRAF V600E-mutant epithelioid glioblastoma to combination therapy with BRAF and MEK inhibitor: establishment and xenograft of a cell line to predict clinical efficacy

Yu Kanemaru, Manabu Natsumeda, Masayasu Okada et al. · Acta Neuropathologica Communications · 2019 · 69 citations · Full text

Medicine, Molecular Genetics, Oncology +16

A Cyclooxygenase-2 Inhibitor Ameliorates Behavioral Impairments Induced by Striatal Administration of Epidermal Growth Factor

Makoto Mizuno, Hidekazu Sotoyama, Eri Narita et al. · Journal of Neuroscience · 2007 · 36 citations · Full text

Medicine, Neuroscience, Pharmacology +14

ErbB inhibitors ameliorate behavioral impairments of an animal model for schizophrenia: implication of their dopamine-modulatory actions

Makoto Mizuno, Hidekazu Sotoyama, Hisaaki Namba et al. · Translational Psychiatry · 2013 · 28 citations · Full text

Medicine, Neuroscience, Pharmacology +16

EGFRvIII Is Expressed in Cellular Areas of Tumor in a Subset of Glioblastoma

Takanori Nozawa, Masayasu Okada, Manabu Natsumeda et al. · Neurologia medico-chirurgica · 2019 · 22 citations · Full text

Medicine, Cancer Biology, Molecular Oncology +16

Antipsychotic Potential of Quinazoline ErbB1 Inhibitors in a Schizophrenia Model Established With Neonatal Hippocampal Lesioning

Makoto Mizuno, Yuriko Iwakura, Masako Shibuya et al. · Journal of Pharmacological Sciences · 2010 · 18 citations · Full text

Medicine, Neuroscience, Pharmacology +12